Somabhai Ishwarbhai Bhagat v. Natwerlal Chhanalal And Co. And Ors.

169364

The petitioner filed a civil suit alleging infringement of Patent No. 124131, which covered a roasting apparatus. The respondent counterclaimed seeking revocation of the patent. The court examined whether the suits and counterclaims were premature because they were filed before the official sealing date of the patent.

Jurisdiction
India
Court
Gujarat High Court
Case Number
169364
Judge(s)
D.A. Desai

Detailed Summary

In the world of intellectual property, enthusiasm can be a dangerous thing.

Practitioner Note

This case demonstrates the evidentiary and procedural standards applied in patent matters before Gujarat High Court. Understanding the court's reasoning in Somabhai Ishwarbhai Bhagat vs Natwerlal Chhanalal And Co. And Ors. is valuable context for structuring arguments or assessing risk in similar proceedings.

Related Cases

patent37649642

Boehringer Ingelheim Pharma GmbH & Co. KGvsMSN Laboratories Private Limited

The plaintiffs, Boehringer Ingelheim Pharma, filed applications seeking interim directions against respondents (including MSN Laboratories and others) for infringing their patent rights related to the medicinal product Linagliptin. The court found that the defendants had not presented a credible challenge to the patent's validity and tilted the balance of convenience in favor of the plaintiffs.

patent200400

Hiroo Khushalani & Anr.vsBaker Hughes Ltd., Uk & Anr.

This appeal addressed an interim injunction sought by Baker Hughes Ltd. to prevent the use of its corporate name 'Baker' by an Indian company (second appellant). The core dispute revolved around a contractual clause stipulating that the Indian company must drop the name if the plaintiff's shareholding fell below 40%. The Delhi High Court ultimately allowed the appeal, finding that the restrictive clause was likely violative of government approval conditions and public policy, thereby dismissing the interim relief.

patent176152364

Bristol-Myers Squibb Holdings Ireland Unlimited Company & Ors.vsBdr Pharmaceuticals International Pvt. Ltd. & Anr.

The plaintiffs, owners of Patent IN-381 covering the molecule APIXABAN (Eliquis®), filed a suit against Bdr Pharmaceuticals for allegedly manufacturing and intending to supply generic versions of this patented drug. The court considered arguments regarding infringement and the validity of the patent based on prior art documents submitted by the defendant.

patent161483119

Groz-Beckert KgvsUnion Of India & Ors.

Groz-Beckert Kg appealed an order from the Assistant Controller rejecting its patent application for a method and apparatus related to processing tape-shaped material. The rejection was based on lack of inventive step, citing prior art (D4).

patent110449599

M/s.Kaleesuwari Refinery Private LimitedvsM/s.Jaya Sai Traders

M/s.Kaleesuwari Refinery Private Limited filed a civil suit seeking permanent injunctions against M/s.Jaya Sai Traders for alleged infringement of its registered trademark 'DHEEPAM' and copyright violation related to the packaging of lamp oil. The plaintiff claimed that the defendant was using deceptively similar marks ('PANCHA DEEPAM OIL') and trade dress, leading to passing off. However, before the court could rule on the merits of the IP infringement claims, the plaintiff chose to withdraw the suit.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call